Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ex-Pfizer Employee Overseeing Xeljanz Global Marketing Sued For Trade Secret Theft

Executive Summary

Pfizer says its former global marketing director emailed and copied hundreds of documents on product launch plans and steps to obtain government approvals before leaving the company in January.

Advertisement

Related Content

Par Alleges 'Shocking' Trade Secret Theft By QuVa Pharma
Pfizer Ex-Marketing Director Agrees To Injunction, Ending Trade Secret Suit
Amgen Alleges 'Massive Conspiracy' By Employees Who Joined Coherus And KBI
Amgen Alleges 'Massive Conspiracy' By Employees Who Joined Coherus And KBI
Biosimilar Trade Secrets: Coherus Hiring Of Amgen Exec Leads To Theft Suit
10 Approvals To Watch For In Early 2017
Pfizer's Xeljanz Set To Lag Lilly's Olumiant In Europe Following Past Rebuffs
World-Top Scientist Busted For Stealing GSK Secrets
Xeljanz Development Plans Scaled Back By Pfizer
Lilly Trade Secrets Theft Case In China Puts Spotlight On Prevalent Problem

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS120133

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel